Equities research analysts expect that CIGNA Co. (NYSE:CI) will report $11.01 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for CIGNA’s earnings, with estimates ranging from $10.92 billion to $11.11 billion. CIGNA posted sales of $10.34 billion in the same quarter last year, which would indicate a positive year over year growth rate of 6.5%. The business is scheduled to report its next earnings results on Friday, May 4th.
On average, analysts expect that CIGNA will report full year sales of $11.01 billion for the current year, with estimates ranging from $43.31 billion to $44.59 billion. For the next financial year, analysts expect that the business will post sales of $47.65 billion per share, with estimates ranging from $46.95 billion to $48.06 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for CIGNA.
CIGNA (NYSE:CI) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.07. The firm had revenue of $10.53 billion during the quarter, compared to analysts’ expectations of $10.28 billion. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. CIGNA’s revenue was up 5.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.87 earnings per share.
Shares of CIGNA (CI) traded down $4.01 during mid-day trading on Friday, reaching $169.35. The company had a trading volume of 1,792,381 shares, compared to its average volume of 1,855,952. The firm has a market capitalization of $42,104.88, a PE ratio of 19.46, a PEG ratio of 1.04 and a beta of 0.51. CIGNA has a 52-week low of $143.85 and a 52-week high of $227.13. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.37 and a current ratio of 0.37.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Monday, March 12th will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.09%. The ex-dividend date of this dividend is Friday, March 9th. CIGNA’s dividend payout ratio (DPR) is presently 0.46%.
In other news, CEO David Cordani sold 36,769 shares of the company’s stock in a transaction on Monday, March 5th. The shares were sold at an average price of $191.68, for a total value of $7,047,881.92. Following the transaction, the chief executive officer now directly owns 372,076 shares of the company’s stock, valued at $71,319,527.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Christopher J. Hocevar sold 2,759 shares of the stock in a transaction on Monday, March 5th. The stock was sold at an average price of $191.84, for a total transaction of $529,286.56. Following the transaction, the insider now directly owns 12,784 shares in the company, valued at $2,452,482.56. The disclosure for this sale can be found here. Insiders sold 86,103 shares of company stock worth $17,217,951 over the last ninety days. 1.30% of the stock is currently owned by company insiders.
A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. increased its position in CIGNA by 1.2% during the fourth quarter. BlackRock Inc. now owns 17,155,180 shares of the health services provider’s stock worth $3,484,045,000 after buying an additional 206,718 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of CIGNA by 4.8% during the third quarter. Ameriprise Financial Inc. now owns 3,776,414 shares of the health services provider’s stock worth $705,889,000 after purchasing an additional 171,712 shares in the last quarter. Sanders Capital LLC boosted its position in shares of CIGNA by 1.8% during the fourth quarter. Sanders Capital LLC now owns 3,015,393 shares of the health services provider’s stock worth $667,646,000 after purchasing an additional 52,400 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of CIGNA by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 2,419,889 shares of the health services provider’s stock worth $490,343,000 after purchasing an additional 40,144 shares in the last quarter. Finally, Swedbank boosted its position in shares of CIGNA by 9.0% during the fourth quarter. Swedbank now owns 1,936,346 shares of the health services provider’s stock worth $393,253,000 after purchasing an additional 159,769 shares in the last quarter. 88.87% of the stock is currently owned by hedge funds and other institutional investors.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.